 Angela Czaja
Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 8 | 2020 | 148 | 2.360 |
Why?
| | Critical Illness | 6 | 2021 | 640 | 1.860 |
Why?
| | Arrhythmias, Cardiac | 3 | 2020 | 282 | 1.690 |
Why?
| | Off-Label Use | 3 | 2023 | 51 | 1.150 |
Why?
| | Patient Readmission | 4 | 2014 | 607 | 1.120 |
Why?
| | Medicine | 3 | 2023 | 102 | 1.070 |
Why?
| | Palliative Care | 2 | 2021 | 641 | 0.960 |
Why?
| | Catheterization, Central Venous | 2 | 2022 | 83 | 0.920 |
Why?
| | Practice Patterns, Physicians' | 3 | 2017 | 1175 | 0.860 |
Why?
| | Child | 32 | 2023 | 18401 | 0.840 |
Why?
| | Critical Care | 5 | 2022 | 472 | 0.820 |
Why?
| | Central Venous Catheters | 1 | 2022 | 40 | 0.790 |
Why?
| | Simulation Training | 1 | 2022 | 62 | 0.750 |
Why?
| | International Classification of Diseases | 2 | 2020 | 116 | 0.730 |
Why?
| | Quality Indicators, Health Care | 2 | 2014 | 285 | 0.730 |
Why?
| | Child, Preschool | 17 | 2021 | 9114 | 0.640 |
Why?
| | Intermittent Positive-Pressure Ventilation | 1 | 2018 | 9 | 0.610 |
Why?
| | Cannula | 1 | 2018 | 17 | 0.610 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2018 | 32 | 0.600 |
Why?
| | Healthcare Disparities | 2 | 2014 | 479 | 0.600 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2018 | 63 | 0.590 |
Why?
| | Positive-Pressure Respiration | 1 | 2017 | 68 | 0.570 |
Why?
| | Noninvasive Ventilation | 1 | 2017 | 31 | 0.560 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2018 | 127 | 0.550 |
Why?
| | Heart Arrest | 1 | 2020 | 293 | 0.530 |
Why?
| | Enteral Nutrition | 1 | 2017 | 157 | 0.520 |
Why?
| | Retrospective Studies | 14 | 2022 | 12521 | 0.500 |
Why?
| | Infant | 15 | 2020 | 7943 | 0.500 |
Why?
| | Physicians | 1 | 2023 | 765 | 0.490 |
Why?
| | Databases, Factual | 5 | 2020 | 1125 | 0.480 |
Why?
| | Respiratory Insufficiency | 1 | 2018 | 286 | 0.470 |
Why?
| | Heart Diseases | 2 | 2018 | 329 | 0.450 |
Why?
| | Pediatrics | 2 | 2017 | 982 | 0.400 |
Why?
| | Humans | 37 | 2023 | 114045 | 0.390 |
Why?
| | Electronic Health Records | 1 | 2018 | 799 | 0.380 |
Why?
| | Pediatric Nursing | 1 | 2011 | 39 | 0.370 |
Why?
| | Antidepressive Agents | 1 | 2012 | 195 | 0.360 |
Why?
| | Sepsis | 2 | 2022 | 507 | 0.340 |
Why?
| | Length of Stay | 3 | 2021 | 957 | 0.340 |
Why?
| | Fellowships and Scholarships | 3 | 2022 | 224 | 0.340 |
Why?
| | Adolescent | 16 | 2023 | 17800 | 0.340 |
Why?
| | Infant, Newborn | 8 | 2023 | 5038 | 0.340 |
Why?
| | Thoracic Surgery | 1 | 2011 | 106 | 0.330 |
Why?
| | Hospitals, Pediatric | 3 | 2021 | 478 | 0.330 |
Why?
| | Nursing Staff, Hospital | 1 | 2011 | 123 | 0.330 |
Why?
| | Hospital Mortality | 4 | 2021 | 773 | 0.330 |
Why?
| | Dexmedetomidine | 1 | 2009 | 45 | 0.310 |
Why?
| | Education, Medical, Graduate | 2 | 2023 | 366 | 0.310 |
Why?
| | Emergencies | 1 | 2009 | 143 | 0.300 |
Why?
| | Hypnotics and Sedatives | 1 | 2009 | 133 | 0.300 |
Why?
| | Cohort Studies | 6 | 2020 | 4883 | 0.290 |
Why?
| | United States | 10 | 2022 | 12137 | 0.280 |
Why?
| | Female | 16 | 2021 | 59324 | 0.260 |
Why?
| | Clinical Competence | 2 | 2022 | 882 | 0.260 |
Why?
| | Male | 17 | 2021 | 55396 | 0.250 |
Why?
| | Risk Factors | 7 | 2020 | 8614 | 0.240 |
Why?
| | Age Factors | 3 | 2020 | 2885 | 0.230 |
Why?
| | Consensus | 2 | 2023 | 532 | 0.230 |
Why?
| | United States Food and Drug Administration | 2 | 2017 | 172 | 0.230 |
Why?
| | Logistic Models | 3 | 2020 | 1829 | 0.230 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2011 | 757 | 0.210 |
Why?
| | Intubation, Intratracheal | 2 | 2018 | 214 | 0.210 |
Why?
| | Delphi Technique | 1 | 2023 | 157 | 0.210 |
Why?
| | Wounds and Injuries | 1 | 2009 | 674 | 0.200 |
Why?
| | Faculty | 1 | 2023 | 126 | 0.200 |
Why?
| | Ultrasonography, Interventional | 1 | 2022 | 120 | 0.190 |
Why?
| | Central Nervous System Stimulants | 1 | 2023 | 140 | 0.190 |
Why?
| | Young Adult | 6 | 2020 | 10444 | 0.190 |
Why?
| | Prescription Drugs | 1 | 2023 | 116 | 0.180 |
Why?
| | Femoral Vein | 1 | 2020 | 29 | 0.180 |
Why?
| | Citalopram | 1 | 2020 | 28 | 0.170 |
Why?
| | Risk Assessment | 3 | 2017 | 2958 | 0.170 |
Why?
| | Shock, Septic | 1 | 2022 | 185 | 0.170 |
Why?
| | Washington | 2 | 2011 | 134 | 0.170 |
Why?
| | Health Status Indicators | 2 | 2011 | 155 | 0.160 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 662 | 0.160 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2020 | 80 | 0.160 |
Why?
| | Adult | 8 | 2021 | 30375 | 0.160 |
Why?
| | Curriculum | 2 | 2022 | 813 | 0.160 |
Why?
| | Proportional Hazards Models | 2 | 2013 | 1078 | 0.150 |
Why?
| | Coronary Care Units | 1 | 2018 | 13 | 0.150 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2018 | 68 | 0.150 |
Why?
| | Faculty, Medical | 1 | 2020 | 226 | 0.140 |
Why?
| | Odds Ratio | 1 | 2020 | 951 | 0.140 |
Why?
| | Family Practice | 1 | 2021 | 426 | 0.140 |
Why?
| | Hospitalization | 2 | 2020 | 1762 | 0.140 |
Why?
| | Delirium | 1 | 2018 | 66 | 0.140 |
Why?
| | Intensive Care Units | 1 | 2021 | 614 | 0.140 |
Why?
| | Administration, Inhalation | 1 | 2018 | 637 | 0.130 |
Why?
| | Internship and Residency | 2 | 2022 | 920 | 0.130 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2020 | 371 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2021 | 632 | 0.130 |
Why?
| | Pharmacoepidemiology | 1 | 2016 | 20 | 0.130 |
Why?
| | Epidemiologic Research Design | 1 | 2016 | 27 | 0.130 |
Why?
| | Comorbidity | 2 | 2011 | 1447 | 0.130 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 239 | 0.120 |
Why?
| | Health Policy | 1 | 2017 | 330 | 0.110 |
Why?
| | Cross-Sectional Studies | 4 | 2023 | 4402 | 0.110 |
Why?
| | Needs Assessment | 3 | 2022 | 315 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2020 | 3003 | 0.110 |
Why?
| | Insurance Claim Review | 1 | 2013 | 68 | 0.100 |
Why?
| | Reproducibility of Results | 2 | 2018 | 2764 | 0.100 |
Why?
| | Algorithms | 1 | 2020 | 1469 | 0.100 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 164 | 0.100 |
Why?
| | Patient Discharge | 2 | 2022 | 770 | 0.100 |
Why?
| | Time Factors | 2 | 2013 | 6077 | 0.100 |
Why?
| | Drug Approval | 1 | 2012 | 78 | 0.100 |
Why?
| | Patient Admission | 1 | 2013 | 175 | 0.100 |
Why?
| | Managed Care Programs | 1 | 2012 | 133 | 0.090 |
Why?
| | Nursing Methodology Research | 1 | 2011 | 38 | 0.090 |
Why?
| | Hospital Units | 1 | 2011 | 23 | 0.090 |
Why?
| | Incidence | 2 | 2018 | 2314 | 0.090 |
Why?
| | Biomedical Research | 1 | 2017 | 582 | 0.090 |
Why?
| | Cardiac Output | 1 | 2011 | 143 | 0.090 |
Why?
| | Aged | 3 | 2021 | 18969 | 0.090 |
Why?
| | Multivariate Analysis | 2 | 2018 | 1422 | 0.090 |
Why?
| | Anesthetics, Intravenous | 1 | 2010 | 27 | 0.090 |
Why?
| | Risk | 1 | 2013 | 810 | 0.090 |
Why?
| | Ventilator Weaning | 1 | 2010 | 33 | 0.090 |
Why?
| | Risk Adjustment | 1 | 2011 | 76 | 0.090 |
Why?
| | Propofol | 1 | 2010 | 43 | 0.090 |
Why?
| | Colorado | 2 | 2017 | 4090 | 0.090 |
Why?
| | Prognosis | 3 | 2018 | 3315 | 0.080 |
Why?
| | Models, Statistical | 1 | 2013 | 595 | 0.080 |
Why?
| | Device Removal | 1 | 2010 | 123 | 0.080 |
Why?
| | Postoperative Care | 1 | 2010 | 223 | 0.080 |
Why?
| | Surveys and Questionnaires | 4 | 2021 | 4595 | 0.070 |
Why?
| | Cardiomyopathies | 1 | 2011 | 298 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2013 | 9049 | 0.070 |
Why?
| | Chronic Disease | 1 | 2013 | 1577 | 0.070 |
Why?
| | Cardiac Catheterization | 1 | 2011 | 545 | 0.070 |
Why?
| | Follow-Up Studies | 2 | 2013 | 4392 | 0.070 |
Why?
| | Prospective Studies | 4 | 2022 | 6195 | 0.070 |
Why?
| | Cause of Death | 1 | 2009 | 362 | 0.070 |
Why?
| | Ibuprofen | 1 | 2007 | 75 | 0.070 |
Why?
| | Burnout, Professional | 1 | 2011 | 323 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2384 | 0.060 |
Why?
| | Heart Transplantation | 1 | 2011 | 670 | 0.060 |
Why?
| | Anxiety | 1 | 2011 | 843 | 0.060 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 296 | 0.060 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2007 | 241 | 0.060 |
Why?
| | Pandemics | 2 | 2023 | 1310 | 0.060 |
Why?
| | Heart Defects, Congenital | 1 | 2010 | 683 | 0.060 |
Why?
| | Suicide, Attempted | 1 | 2007 | 316 | 0.060 |
Why?
| | Middle Aged | 3 | 2021 | 26605 | 0.060 |
Why?
| | Depression | 1 | 2011 | 1133 | 0.050 |
Why?
| | Obesity | 1 | 2015 | 2505 | 0.050 |
Why?
| | Psychotropic Drugs | 1 | 2023 | 54 | 0.050 |
Why?
| | Competency-Based Education | 1 | 2022 | 62 | 0.050 |
Why?
| | Health Resources | 1 | 2022 | 120 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2011 | 1736 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 186 | 0.040 |
Why?
| | Certification | 1 | 2020 | 84 | 0.040 |
Why?
| | Survivors | 1 | 2022 | 412 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2009 | 6306 | 0.040 |
Why?
| | Teaching | 1 | 2020 | 209 | 0.040 |
Why?
| | Qualitative Research | 1 | 2022 | 919 | 0.040 |
Why?
| | Ultrasonography | 1 | 2020 | 635 | 0.040 |
Why?
| | Stroke Volume | 1 | 2020 | 513 | 0.030 |
Why?
| | Echocardiography | 1 | 2020 | 569 | 0.030 |
Why?
| | International Agencies | 1 | 2016 | 29 | 0.030 |
Why?
| | Sample Size | 1 | 2016 | 109 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2020 | 526 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 768 | 0.030 |
Why?
| | Pharmacokinetics | 1 | 2015 | 25 | 0.030 |
Why?
| | Information Dissemination | 1 | 2015 | 185 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2015 | 237 | 0.030 |
Why?
| | Decision Support Systems, Clinical | 1 | 2015 | 175 | 0.030 |
Why?
| | Body Weight | 1 | 2015 | 868 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2011 | 248 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 945 | 0.020 |
Why?
| | Pilot Projects | 1 | 2011 | 1360 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 1836 | 0.020 |
Why?
|
|
Czaja's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|